Physician profile
Bradley Andersen
NPI 1528018470
$3,650.46
in general payments reported to CMS, 2019-2025
19 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $710 · 2020: $143 · 2022: $630 · 2023: $538 · 2024: $446 · 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $726.64 | 2022-2025 | Otezla, Otezla, Enbrel |
| Abbvie INC. | $611.44 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $374.98 | 2022-2023 | Saphnelo |
| Novartis Pharmaceuticals Corporation | $374.33 | 2019-2025 | |
| Ucb, INC. | $315.60 | 2023-2025 | Bimzelx, Cimzia |
| Glaxosmithkline, LLC. | $180.81 | 2020-2023 | Benlysta |
| Pfizer INC. | $160.96 | 2019-2025 | |
| Lilly USA, LLC | $134.39 | 2019-2023 | Mounjaro |
| Abbott Laboratories | $127.96 | 2023-2025 | Freestyle Libre 3 |
| Horizon Therapeutics Plc | $123.97 | 2022 | |
| Genentech USA, INC. | $116.30 | 2019 | |
| Janssen Scientific Affairs, LLC | $112.50 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $104.56 | 2019 | |
| Aurinia Pharma U.S., INC. | $65.52 | 2025 | Lupkynis |
| Genzyme Corporation | $35.99 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.63 | 2023 | Cyltezo |
| Ascendis Pharma Endocrinology INC | $20.61 | 2024 | |
| Acella Pharmaceuticals, LLC | $16.63 | 2025 | NP Thyroid 60 |
| Corcept Therapeutics | $14.64 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.